EUVIMEDEUVIMED entdecken
Crossref

Genetically Edited Cascade Nanozymes for Cancer Immunotherapy

Jing Zhang, Yuanwei Pan, Lujie Liu, Yangtao Xu, Chenchen Zhao, Wei Liu iD, Lang Rao iD

ACS Nano · 14.05.2024 · 18 (19) · 12295-12310

DOI: 10.1021/acsnano.4c01229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 02.05.2024. Verfasst von Jing Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Artificial Micro- and Nano-Structures of Ministry of Education, School of Physics and Technology, Wuhan University, Wuhan 430072, C…. Hauptthemen laut MEDLINE: Immunotherapy. Die Arbeit wurde bisher 97-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Science and Technology Foundation of Shenzhen City, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyAnimalsMiceFemaleHumansTumor MicroenvironmentDendritic CellsMice, Inbred BALB CCell Line, TumorImmunogenic Cell DeathMembrane ProteinsNanoparticles

Stichwörter der Autor:innen

cGAS-STING pathwaycancer immunotherapycascade nanozymesgenetic engineeringimmune activationimmunogenic cell death

Substanzen

Membrane Proteins

Autor:innen und Institutionen

  • Key Laboratory of Artificial Micro- and Nano-Structures of Ministry of Education, School of Physics and Technology, Wuhan University, Wuhan 430072, China.
  • Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen 518132, China.
  • Cancer Center, Renmin Hospital of Wuhan University, Wuhan 430060, China.
  • School of Mathematical and Physical Sciences, Wuhan Textile University, Wuhan 430200, China.

ORCID-Profile: Wei Liu, Lang Rao

Förderung

  • National Key Research and Development Program of China
  • Science and Technology Foundation of Shenzhen City
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Hubei Luojia Laboratory

Zitieren

APA

Zhang, J., Pan, Y., Liu, L., Xu, Y., Zhao, C., Liu, W., & Rao, L. (2024). Genetically Edited Cascade Nanozymes for Cancer Immunotherapy. ACS Nano, 18(19), 12295-12310. https://doi.org/10.1021/acsnano.4c01229

Vancouver

Zhang J, Pan Y, Liu L, Xu Y, Zhao C, Liu W, et al. Genetically Edited Cascade Nanozymes for Cancer Immunotherapy. ACS Nano. 2024;18(19):12295-12310. doi:10.1021/acsnano.4c01229

BibTeX
@article{Zhang2024,
  author = {Zhang, Jing and Pan, Yuanwei and Liu, Lujie and Xu, Yangtao and Zhao, Chenchen and Liu, Wei and Rao, Lang},
  title = {Genetically Edited Cascade Nanozymes for Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {19},
  pages = {12295--12310},
  doi = {10.1021/acsnano.4c01229}
}
Kostenlos starten →